scholarly article | Q13442814 |
P2093 | author name string | K Matsumoto | |
B S Bochner | |||
C A Bickel | |||
R P Schleimer | |||
L A Beck | |||
J Appiah-Pippim | |||
P2860 | cites work | CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration | Q24680875 |
The migration of eosinophils into the sputum of asthmatics: the role of adhesion molecules | Q36114997 | ||
Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan | Q36236582 | ||
Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition | Q36352001 | ||
T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis | Q36363699 | ||
Glycosylation of CD44 negatively regulates its recognition of hyaluronan | Q36365225 | ||
CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway | Q36365827 | ||
The immunobiology of eosinophils | Q37676921 | ||
Hypodense eosinophils in allergic rhinitis | Q40785425 | ||
CD40 ligand is functionally expressed on human eosinophils | Q41365568 | ||
Phenotypic characterization of KU812, a cell line identified as an immature human basophilic leukocyte | Q41609729 | ||
Down-regulation by tumor necrosis factor-alpha of neutrophil cell surface expression of the sialophorin CD43 and the hyaluronate receptor CD44 through a proteolytic mechanism | Q44272775 | ||
P433 | issue | 6 | |
P921 | main subject | human eosinophil | Q101405048 |
P304 | page(s) | 860-866 | |
P577 | publication date | 1998-06-01 | |
P1433 | published in | American Journal of Respiratory Cell and Molecular Biology | Q4744268 |
P1476 | title | CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils | |
P478 | volume | 18 |
Q26853383 | Activation states of blood eosinophils in asthma |
Q33773048 | Advances in the immunobiology of eosinophils and their role in disease |
Q57273168 | Analysis of gene expression in peripheral blood eosinophils from patients with atopic dermatitis and in vitro cytokine-stimulated blood eosinophils |
Q35864846 | Anti-CD69 monoclonal antibody treatment inhibits airway inflammation in a mouse model of asthma |
Q36139731 | Biomarkers of eosinophil involvement in allergic and eosinophilic diseases: review of phenotypic and serum markers including a novel assay to quantify levels of soluble Siglec-8 |
Q37238312 | CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis. |
Q47225624 | Corticosteroid and cytokines synergistically enhance toll-like receptor 2 expression in respiratory epithelial cells |
Q50441079 | Cyclopamine induces eosinophilic differentiation and upregulates CD44 expression in myeloid leukemia cells |
Q98779284 | Elevated Levels of Activated and Pathogenic Eosinophils Characterize Moderate-Severe House Dust Mite Allergic Rhinitis |
Q33785627 | Eosinophil Activation Status in Separate Compartments and Association with Asthma |
Q35598016 | Eosinophil granulocytes are activated during the remission phase of ulcerative colitis |
Q27028076 | Eosinophils in infection and intestinal immunity |
Q34442851 | Eosinophils in the blood of hematopoietic stem cell transplanted patients are activated and have different molecular marker profiles in acute and chronic graft-versus-host disease |
Q51642669 | Expression of interleukin-5- and granulocyte macrophage-colony-stimulating factor-responsive genes in blood and airway eosinophils. |
Q35609658 | Human eosinophil-airway smooth muscle cell interactions |
Q51552201 | Immunohistochemical differentiation of eosinophilic heart diseases using antibodies against eosinophil activation markers. |
Q77999484 | Increased CD69 expression on peripheral blood eosinophils after specific inhalation challenge |
Q44210307 | Interleukin-3, but not granulocyte-macrophage colony-stimulating factor and interleukin-5, inhibits apoptosis of human basophils through phosphatidylinositol 3-kinase: requirement of NF-kappaB-dependent and -independent pathways |
Q36119800 | Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders |
Q47786031 | Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma. |
Q47964479 | Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease. |
Q44016398 | Migration through basement membrane modulates eosinophil expression of CD44. |
Q37260287 | Nonhematopoietic NADPH oxidase regulation of lung eosinophilia and airway hyperresponsiveness in experimentally induced asthma |
Q73478398 | Overexpression of CD44 on alveolar eosinophils with high concentrations of soluble CD44 in bronchoalveolar lavage fluid in patients with eosinophilic pneumonia |
Q39752337 | Peptidoglycan induces mobilization of the surface marker for activation marker CD66b in human neutrophils but not in eosinophils |
Q53567163 | Regulation of functional phenotypes of cord blood derived eosinophils by gamma-secretase inhibitor. |
Q33760636 | Sputum hyaluronan and versican in severe eosinophilic asthma |
Q44751339 | The promotion of eosinophil degranulation and adhesion to conjunctival epithelial cells by IgE-activated conjunctival mast cells |
Q46428061 | The synthetic PPARgamma agonist troglitazone inhibits IL-5-induced CD69 upregulation and eosinophil-derived neurotoxin release from eosinophils |
Q33737395 | Toward the Proteome of the Human Peripheral Blood Eosinophil |
Q36456483 | Trial watch: Prognostic and predictive value of the immune infiltrate in cancer |
Q24629299 | Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling |
Q82487956 | [Activated eosinophils: techniques to characterize them] |
Q22008473 | alphadbeta2 integrin is expressed on human eosinophils and functions as an alternative ligand for vascular cell adhesion molecule 1 (VCAM-1) |
Search more.